| Intrinsic Valuation of: DIVISLAB | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 82 | Market Cap | ₹1,820B | |||||
| 2021 | - | - (-) | P/E Ratio | 83 | Total Asset | ₹169B | |||||
| 2022 | ₹12B | - (-) | Net Income | ₹22B | Total Debt | ₹0 | |||||
| 2023 | ₹20B | 65.7% (90.2%) | EBITDA | ₹33B | Total Liab | ₹20B | |||||
| 2024 | ₹3B | -87.0% (-87.3%) | Opr Margin | 0.27 | Debt/Equity | - | |||||
| 2025 | ₹2B | -16.7% (-30.2%) | PreTax Margin | 27.39 | BV/Share | 564 | |||||
| 5Y Average FCF | ₹9B | -12.7% (-9.1%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | ₹2B | MBG Intrinsic Value | ₹736 | ||||||||
| 2027 | ₹2B | ||||||||||
| 2028 | ₹2B | ||||||||||
| 2029 | ₹3B | ||||||||||
| 2030 | ₹3B | ||||||||||
| 2031 | ₹3B | ||||||||||
| Terminal Value | ₹57B | Net Worth/Share | ₹564 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹48B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹4B | ₹198 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 7.3% | 176 | 187 | 201 | 219 | 240 | |||
| Equity Value | ₹52B | 7.4% | 175 | 186 | 200 | 216 | 237 | ||||
| Shares Outstanding | 265,468,992 | 7.4% | 173 | 184 | 198 | 214 | 235 | ||||
| 7.9% | 161 | 170 | 181 | 194 | 210 | ||||||
| DCF Intrinsic Value | ₹198 | 8.4% | 150 | 158 | 167 | 177 | 190 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||